Centre for Anaesthesia, Critical Care and Pain Medicine, University College London, UK.
Crit Care Med. 2010 Feb;38(2):388-94. doi: 10.1097/CCM.0b013e3181c03dfa.
To explore the hypothesis that beta-1 adrenoreceptor blockade may be protective through the attenuation of sympathetic hyperactivity and catecholaminergic inflammatory effects on cardiac and hepatic function.
Prospective, randomized, controlled study.
Animal laboratory in a university medical center.
Male adult Wistar rats.
Peripheral beta1-adrenoceptor blockade through daily intraperitoneal injection (metoprolol, 100 mg x kg(-1); atenolol, 6 mg x kg(-1)) or central nervous system beta1-adrenoceptor blockade (intracerebroventricular metoprolol, 25 microg) to achieve approximately 20% heart rate reduction in rats for 2 days before or after the induction of lethal endotoxemia, cecal ligation and puncture, or fecal peritonitis.
Peripheral beta1-adrenoceptor blockade established for 2 days before lethal endotoxemia markedly improved survival in both metoprolol-treated (n = 16; log rank test, p = .002) and atenolol-treated (n = 15; p = .03) rats. Overall mortality in cecal ligation and puncture was similar between metoprolol (40%; n = 10) and saline (50%; n = 10) pretreatment (p = .56), but the median time to death was increased by 33 hrs in metoprolol-treated rats (p = .03). Metoprolol pretreatment reduced hepatic expression of proinflammatory cytokines and lowered plasma interleukin-6 (both p < .05). Myocardial protein expression of interleukin-18 and monocyte chemoattractant protein-1, key mediators of cardiac dysfunction in sepsis, were also reduced (p < .05). Peripheral beta1-adrenoceptor blockade commenced 6 hrs after lethal endotoxemia or fecal peritonitis did not improve survival. However, arterial blood pressure was preserved and left ventricular contractility restored similar to that found in nonseptic controls. Central nervous system beta1-adrenoceptor blockade (metoprolol) did not reduce plasma cytokines or mortality, despite enhancing parasympathetic tone.
Peripheral beta1-adrenoceptor blockade offers anti-inflammatory and cardioprotective effects, with mortality reduction if commenced before a septic insult. Its role in sepsis should be explored further.
通过减弱交感神经活性和儿茶酚胺的炎症作用对心、肝功能的影响,探讨β-1 肾上腺素能受体阻断可能具有保护作用的假说。
前瞻性、随机、对照研究。
大学医学中心的动物实验室。
雄性成年 Wistar 大鼠。
通过每日腹腔内注射(美托洛尔,100mg·kg-1;阿替洛尔,6mg·kg-1)或中枢神经系统β1-肾上腺素能受体阻断(侧脑室给予美托洛尔,25μg),使大鼠心率降低约 20%,持续 2 天,然后再进行致死性内毒素血症、盲肠结扎穿孔或粪便性腹膜炎诱导。
在致死性内毒素血症前 2 天建立外周β1-肾上腺素能受体阻断,明显改善了美托洛尔治疗组(n=16;对数秩检验,p=0.002)和阿替洛尔治疗组(n=15;p=0.03)大鼠的存活率。盲肠结扎穿孔中,美托洛尔(40%;n=10)和生理盐水(50%;n=10)预处理之间的总死亡率相似(p=0.56),但美托洛尔治疗组大鼠的死亡中位时间延长了 33 小时(p=0.03)。美托洛尔预处理降低了肝内促炎细胞因子的表达,并降低了血浆白细胞介素-6(均 p<0.05)。败血症中心功能障碍的关键介质白细胞介素-18 和单核细胞趋化蛋白-1 的心肌蛋白表达也减少(p<0.05)。致死性内毒素血症或粪便性腹膜炎发生后 6 小时开始的外周β1-肾上腺素能受体阻断不能提高生存率。然而,动脉血压得以维持,左心室收缩力恢复到非感染性对照组的水平。尽管增强了副交感神经张力,但中枢神经系统β1-肾上腺素能受体阻断(美托洛尔)并没有降低血浆细胞因子或死亡率。
外周β1-肾上腺素能受体阻断具有抗炎和心脏保护作用,如果在感染性损伤之前开始,可降低死亡率。应进一步探讨其在败血症中的作用。